These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 27672290)

  • 21. MicroRNAs in prostate cancer: Functional role as biomarkers.
    Kanwal R; Plaga AR; Liu X; Shukla GC; Gupta S
    Cancer Lett; 2017 Oct; 407():9-20. PubMed ID: 28823964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of recent molecular landscape knowledge of gastric cancer.
    Shimizu D; Kanda M; Kodera Y
    Histol Histopathol; 2018 Jan; 33(1):11-26. PubMed ID: 28447336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.
    Jiang C; Chen X; Alattar M; Wei J; Liu H
    Cancer Gene Ther; 2015 Jun; 22(6):291-301. PubMed ID: 25998522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer.
    Otani K; Li X; Arakawa T; Chan FK; Yu J
    Expert Rev Mol Diagn; 2013 Jun; 13(5):445-55. PubMed ID: 23782252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation.
    Ishimoto T; Baba H; Izumi D; Sugihara H; Kurashige J; Iwatsuki M; Tan P
    Int J Cancer; 2016 Mar; 138(6):1337-49. PubMed ID: 26041092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs in the thyroid.
    Boufraqech M; Klubo-Gwiezdzinska J; Kebebew E
    Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):603-619. PubMed ID: 27923454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
    Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
    Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA dysregulation in gastric cancer: a new player enters the game.
    Wu WK; Lee CW; Cho CH; Fan D; Wu K; Yu J; Sung JJ
    Oncogene; 2010 Oct; 29(43):5761-71. PubMed ID: 20802530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of miRNA in endometrial cancer in the context of miRNA 205].
    Wilczyński M; Danielska J; Dzieniecka M; Malinowski A
    Ginekol Pol; 2015 Nov; 86(11):856-61. PubMed ID: 26817318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer type-specific epigenetic changes: gastric cancer.
    Calcagno DQ; de Arruda Cardoso Smith M; Burbano RR
    Methods Mol Biol; 2015; 1238():79-101. PubMed ID: 25421656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA aberrations: An emerging field for gallbladder cancer management.
    Chandra V; Kim JJ; Mittal B; Rai R
    World J Gastroenterol; 2016 Feb; 22(5):1787-99. PubMed ID: 26855538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
    Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P
    Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNAs in cancer: from bench to bedside.
    Cortez MA; Ivan C; Zhou P; Wu X; Ivan M; Calin GA
    Adv Cancer Res; 2010; 108():113-57. PubMed ID: 21034967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
    Yang Z; Guo X; Li G; Shi Y; Li L
    Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of miRNAs in cancer: from pathogenesis to therapeutic implications.
    Seven M; Karatas OF; Duz MB; Ozen M
    Future Oncol; 2014 May; 10(6):1027-48. PubMed ID: 24941988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insight into the role of miRNAs in leukemia.
    Zhang H; Chen Y
    Sci China C Life Sci; 2009 Mar; 52(3):224-31. PubMed ID: 19294347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics/genomics/proteomics of gastric adenocarcinoma.
    Uppal DS; Powell SM
    Gastroenterol Clin North Am; 2013 Jun; 42(2):241-60. PubMed ID: 23639639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells.
    Kong D; Piao YS; Yamashita S; Oshima H; Oguma K; Fushida S; Fujimura T; Minamoto T; Seno H; Yamada Y; Satou K; Ushijima T; Ishikawa TO; Oshima M
    Oncogene; 2012 Aug; 31(35):3949-60. PubMed ID: 22139078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs as potential biomarkers in cancer: opportunities and challenges.
    Lan H; Lu H; Wang X; Jin H
    Biomed Res Int; 2015; 2015():125094. PubMed ID: 25874201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetically silenced microRNAs in gastric cancer: Functional analysis and identification of their target genes.
    Bae JH; Kang MJ; Yang KM; Kim TO; Yi JM
    Oncol Rep; 2015 Aug; 34(2):1017-26. PubMed ID: 26043902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.